Author name: TB Alliance

A study released by the London School of Economics credits public-private partnerships (PPPs), such as the TB Alliance, for the

Stronger incentives to smaller biomedical companies rather than to large pharmaceutical groups could help boost the development of treatments for

New hope in developing drugs for the poor “BIG pharmaceuticals…right up there with the arms dealers,” says a character in

Dr. Mdluli joined the TB Alliance R&D team in May as the Project Leader of Research, working closely with Dr.

For centuries, tuberculosis (TB) has targeted the most vulnerable populations during their most productive working years, threatening economic and social

The UN Millennium Project commissioned and published a series of action plans to outline the steps necessary to achieving the

As part of its historic $50 billion package for Africa, the G8 nations this year announced their support for the

Financial Times Published: June 17 2005 DRUG COMPANIES APPEAL FOR G8 BACKING TO FIGHT DISEASES Some of the world’s leading